Coronavirus channel feed

An­oth­er one bites the dust? FDA warns that emerg­ing Omi­cron sub­vari­ant could make Evusheld ob­so­lete

3 years ago

Mod­er­na re­fused to dis­close mR­NA vac­cine tech­nol­o­gy to Chi­na — re­port

3 years ago
China

In­dus­try groups call to block WTO IP waiv­er ex­pan­sion to Covid-19 ther­a­peu­tics

3 years ago
Law

Covid-19 roundup: Swiss biotech halts in-pa­tient PhII study; Hous­ton-based vac­cine and Chi­nese mR­NA shot nab EUAs in In­done­sia

3 years ago

Covid-19 roundup: Sh­iono­gi’s an­tivi­ral pill hits the mark; Ocu­gen strikes deal for in­tranasal vac­cine

3 years ago

Up­dat­ed: Study iden­ti­fies Covid-19 pa­tients with mu­ta­tions in­di­cat­ing remde­sivir re­sis­tance

3 years ago

Val­ne­va’s sec­ond-gen Covid vac­cine plans up in the air as it looks for part­ner

3 years ago

Covid-19 roundup: Pfiz­er, BioN­Tech kick off EUA dance for teen bi­va­lent shot; Re­port de­tails slow US boost­er roll­out

3 years ago

WHO-backed Afrigen plans a charge to­ward the clin­ic with Africa's first Covid-19 vac­cine

3 years ago

Covid-19 roundup: Mod­er­na sends in EUA for bi­va­lent teen boost­er; US trim­ming Pfiz­er/BioN­Tech do­na­tions

3 years ago

Covid-19 roundup: Man­u­fac­tur­ing con­tract axed for Val­ne­va’s vac­cine; Pen­ny stock halts ear­ly in­fec­tion tri­al

3 years ago

Mod­er­na CEO looks to Japan for build­ing new vac­cine man­u­fac­tur­ing site

3 years ago
Pharma
Manufacturing

Lancet com­mis­sion sharply cri­tiques WHO and gov­ern­ments over their Covid re­sponse

3 years ago

Can a spe­cial chew­ing gum slick away Covid-19 from sali­va? Penn re­searchers start clin­i­cal tri­al to find out

3 years ago
Discovery

FDA hires new vac­cine di­rec­tor, a year af­ter two se­nior lead­ers quit in protest

3 years ago
FDA+

$100 for a Covid-19 vac­cine? That's what Mod­er­na says may be com­ing

3 years ago

A long Covid col­lab­o­ra­tive kicks off with $15M to study caus­es of lin­ger­ing dis­ease, con­duct clin­i­cal tri­als

3 years ago

On the heels of un­prompt­ed EMA re­view of Covid drug, FDA sched­ules ad­comm for po­ten­tial EUA

3 years ago
FDA+

'Vac­cines are not par­ti­san': White House ramps up de­liv­ery of bi­va­lent boost­ers

3 years ago

Covid-19 roundup: CanSi­no’s in­haled vac­cine gets thumbs-up from Chi­nese reg­u­la­tors; Sino­vac gets go-ahead for boost­er tri­al in Chile

3 years ago

Fol­low­ing FDA, CHMP gives thumbs-up on Pfiz­er, BioN­Tech Omi­cron boost­er

3 years ago
Pharma

FDA clears Pfiz­er and Mod­er­na's bi­va­lent boost­ers, seek­ing to slow the next wave of Omi­cron

3 years ago

US ex­pects to soon run out of gov­ern­ment Covid-19 funds for vac­cines, treat­ments

3 years ago

From Aus­tralia, new $173M re­search cen­ter strives to be at the fore­front of pan­dem­ic drug dis­cov­ery

3 years ago
Discovery
First page Previous page 45678910 Next page Last page
A service from the Financial Times